SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...

Understanding the core principles of computer programming is the first step to writing effective code. Learning about ...

D HBM-on-GPU design reaches record compute density for demanding AI workloadsPeak GPU temperatures exceeded 140°C without thermal mitigation strategiesHalving the GPU clock rate reduced temperatures ...

Graphs are everywhere. From technology to finance, they often model valuable information such as people, networks, biological pathways and more. Often, scientists and technologists need to come up ...

As 2026 approaches, Watch With Us has narrowed our selections down to the five best Prime Video movies to watch on New Year’s Eve. Our picks include an outstanding horror flick, ...

We like this tax software for its solid tools for self-employed filers and free federal filing for active military members.

Chinese AI startup’s release is a major update to its open-source model series, aimed at multi-language programming and ...

Performance-driven influencer marketing means you can tie creator activity to outcomes you can count. In plain terms, it’s ...

Wall Street’s favorite AI stock just found a new way to tighten its grip on the data center; rival chipmakers may not like where this is headed.

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...